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Abstract
Background: Reviews indicate that the quality of reporting of randomised controlled trials (RCTs) in the medical
literature is less than optimal, poor to moderate, and require improving. However, the reporting quality of
chiropractic RCTs is unknown.
As a result, the aim of this study was to assess the reporting quality of chiropractic RCTs and identify factors
associated with better reporting quality. We hypothesized that quality of reporting of RCTs was influenced by
industry funding, positive findings, larger sample sizes, latter year of publication and publication in non-chiropractic
journals.
Methods: RCTs published between 2005 and 2014 were sourced from clinical trial registers, PubMed and the
Cochrane Reviews. RCTs were included if they involved high-velocity, low-amplitude (HVLA) spinal and/or extremity
manipulation and were conducted by a chiropractor or within a chiropractic department. Data extraction, and
reviews were conducted by all authors independently. Disagreements were resolved by consensus. Outcomes: a
39-point overall quality of reporting score checklist was developed based on the CONSORT 2010 and CONSORT for
Non-Pharmacological Treatments statements. Four key methodological items, based on allocation concealment,
blinding of participants and assessors, and use of intention-to-treat analysis (ITT) were also investigated.
Results: Thirty-five RCTs were included. The overall quality of reporting score ranged between 10 and 33 (median
score 26.0; IQR = 8.00). Allocation concealment, blinding of participants and assessors and ITT analysis were reported
in 31 (87 %), 16 (46 %), 25 (71 %) and 21 (60 %) of the 35 RCTs respectively. Items most underreported were from
the CONSORT for Non-Pharmacological Treatments statement. Multivariate regression analysis, revealed that year of
publication (t32 = 5.17, p = 0.000, 95 % CI: 0.76, 1.76), and sample size (t32 = 3.01, p = 0.005, 95 % CI: 1.36, 7.02), were
the only two factors associated with reporting quality.
Conclusion: The overall quality of reporting RCTs in chiropractic ranged from poor to excellent, improving
between 2005 and 2014. This study suggests that quality of reporting, was influenced by year of publication
and sample size but not journal type, funding source or outcome positivity. Reporting of some key methodological
items and uptake of items from the CONSORT Extension for Non-Pharmacological Treatments items was suboptimal.
Future recommendations were made.
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Background
Randomised controlled trials (RCTs) are considered to
be the “gold standard” of clinical research [1, 2], by
which health care professionals make decisions about
the efficacy and effectiveness of interventions [3–6].
However, poorly designed and reported studies continue
to be published, leading to a compromised evidence base
[7]. This can adversely influence meta-analysis findings
and clinical practice recommendations [7–10]. As a re-
sult of the poor reporting of RCTs, the CONSORT
(Consolidated Standards of Reporting Trials) statement
was developed in 1996 [6], and updated in 2010 [11],
with the aim of improving the quality of reporting of
RCTs through standardization, comprehensiveness and
transparency [6, 11].
Reporting research in manual therapies presents obsta-
cles not experienced in medical pharmacological trials.
Non-pharmacological trials, such as chiropractic RCTs,
test complex therapeutic interventions, which tend to be
multi-faceted [12]. As a result, they are more challenging
to describe, standardise, reproduce and administer con-
sistently to all participants involved in a clinical trial
[12]. These variants, along with others, such as care
provider’s expertise may substantially impact estimates
of treatment effect [12]. This makes it imperative for
such studies to adhere to the CONSORT 2010 [13] and
CONSORT for Non-Pharmacologic Treatments state-
ments criteria [12].
Reviews indicate that the quality of reporting of RCTs
in the medical literature is less than optimal [14–18]. As
a result, many reviewers have drawn conclusions that
the overall quality of reporting was poor to moderate
[7, 9, 19–21], and require improving [22–26].
To our knowledge there has not been an assess-
ment of the quality of reporting of RCTs in chiro-
practic. As a result, the aim of this study was to
assess the reporting quality of RCTs in chiropractic
and to identify factors associated with better reporting
quality. The candidate factors that were chosen for
this study, have previously been identified in the med-
ical literature as influencing the reporting quality of
RCTs [8, 9, 18].
The objectives of this study were to:
1. Assess the overall quality of reporting of RCTs
in chiropractic using a customised tool, based
on the CONSORT 2010 and CONSORT
for Non-Pharmacologic Treatments statements.
2. To report on 4 key methodological items that
minimise bias, based on allocation concealment,
blinding of participants and assessors, and use of
intention-to-treat analysis.
3. To determine factors associated with higher quality
of reporting.
We hypothesized that quality of reporting was influ-
enced by industry funding, positive findings, larger sam-
ple sizes, latter year of publication and publication in
non-chiropractic journals.
Methods
This study has ethics approval from Murdoch Univer-
sity, Research Ethics and Integrity Office: Ethics #2014/
119. The study protocol has been published previously,
[27] however an outline is presented below.
Study selection
We searched ten clinical trial registers (refer to Fig. 1) and
two electronic databases (PubMed and the Cochrane
Database of Systematic Reviews), to identify publications
of RCTs involving chiropractic studies, published between
January 2005 to July 2014. The search terms used were:
“Spine” OR “Lower Extremity” OR “Upper Extremity”
AND “Musculoskeletal Manipulations” OR, “Manipula-
tion, Chiropractic” OR “Spinal Manipulative Therapy”
AND “Chiropractic”. Full text articles of RCTs in the
English language were included if they met inclusion cri-
teria as outlined in Table 1. Article selection and data
extraction was conducted by all authors independently,
and disagreements were resolved by consensus.
We chose to limit this review to high-velocity, low-
amplitude (HVLA) studies only, as manual manipulative
procedures are the basis of training for all chiropractors.
Furthermore, HVLA procedures are reported to be the
most popular chiropractic adjusting techniques, used by
93 % of chiropractic practitioners in the US, with similar
numbers internationally [28].
It should be recognised that, for the purpose of this
study we have included RCTs where both chiropractors
and non-chiropractors were involved in the delivery of
the interventions, such as physiotherapists, physical
therapists and osteopaths [29–32]. However, the HVLA
interventions were all delivered by a chiropractor who
was part of the study team. We also included studies
where the HVLA intervention was the comparator
rather than the primary intervention [32–36].
Pilot and feasibility studies were not included as the
CONSORT checklist could not be applied to such stud-
ies without them being disadvantaged during scoring, in
that they typically do not include all items from the
CONSORT, such as a power analysis and ITT analysis.
Similarly, studies not published as full papers were not
included, as it is impossible to properly assess those
papers against the CONSORT criteria.
Review strategy
The characteristics of included studies have been reported
in Additional file 1. The characteristics of excluded studies
have been reported in Additional file 2.
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Rating the overall reporting quality
This study was modeled upon previously published
medical studies assessing the quality of reporting
RCTs [9, 14, 16, 18, 19, 37], which used the CONSORT
checklists. Furthermore, the CONSORT was used, as it is
considered to have both face and content validity and is a
measure of methodological quality [38].
A 39-point customised CONSORT checklist was
developed by three authors (FK, RB and BB) in order to
ascertain the overall quality of reporting of chiropractic
RCTs. The overall quality of reporting checklist was
developed by integrating items from the CONSORT
2010 [13], and the CONSORT for Non-Pharmacological
Treatments statements [12]. Twenty-two items were
included from the CONSORT 2010 statement [13], i.e.
items one through to 25, excluding items 21, 22 and 24.
Items 21 (generalizability [external validity] of the trial
findings) and 22 (interpretation of results), which are in-
cluded in the discussion section, were excluded from the
customised checklist because it is challenging to object-
ively evaluate them [7, 39]. Item 24 (access to trial
protocol), was also excluded, as historically it was not a
Fig. 1 Flow diagram of RCT selection (N = 35)
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requirement to publish protocols prior to publication of
results. Items from the CONSORT 2010 checklist
included in our assessment tool are outlined in Table 2.
In addition, nine items from the CONSORT for Non-
Pharmacological Treatments statement [12], were in-
cluded i.e. Extensions 1, 3, 4a, 4b, 4c, 8, 13, 15 and ‘New
Item’ and are outlined in Table 3.
The assessment of the adequacy of reporting, was
based on the CONSORT 2010 guidelines and its exten-
sions [12, 13, 40]. Items were defined as ‘yes’ if they were
clearly and adequately reported and received a score of
1; or ‘no’ if they were unclear or not reported at all, and
received a scored of 0. Items that were not applicable to
a specific study were defined as ‘not applicable’ (‘N/A’)
and were coded 9. The overall quality of reporting score of
the trial was calculated as a percentage of the items rated
as ‘yes’ (with a score ranging between 0 and 39 points).
Key methodological items, that safeguard against
biases [9, 18, 39], have also been reported in the litera-
ture [16], such as: allocation concealment (Item 9),
blinding (Item 11), and use of ITT analysis (Item 16).
The separate assessment of the key methodological
items was deemed necessary because, even within pub-
lished articles with high overall reporting scores, these
are often under reported [38] (Table 4). Blinding of par-
ticipants was scored separately to blinding of assessors.
The question of blinding of care-providers was excluded
for pragmatic purposes. It has been established that
blinding manual therapy practitioners is virtually impos-
sible [41, 42], with similar constraints to the blinding of
surgeons in medical clinical trials [14].
All authors were involved in the scoring of the RCTs.
Each RCT was scored by at least two authors, who were
blinded to each other’s results. Results were collated,
and any discrepancies were resolved via consensus.
Definition of trial characteristics
A “positive finding” in a trial was defined as a trial in
which the chiropractic intervention was deemed by au-
thors to have statistically significant results and hence
was considered superior to the comparator (i.e. placebo/
sham, usual care, standard care, medical care, other
health care modality, no care or other chiropractic inter-
vention). If the trial produced results that stated that the
chiropractic manipulative therapy and the comparator
both produced positive outcomes in the study, then the
RCT was rated as “no” to the question of “positive find-
ing”, as the chiropractic intervention was not deemed
superior to comparator (Refer to Additional file 1).
Trials were considered to be industry-funded, if there
was at least partial industry funding. Industry funding
included chiropractic research organizations, chiroprac-
tic governing bodies or other industry organizations with
potentially vested interests in the research. Chiropractic
departments funding research within private chiropractic
colleges were also deemed to be industry funding,
whereas chiropractic and non-chiropractic departments
within government educational institutions were consid-
ered to be non-industry. Trials that did not have any
funding, were also classified as non-industry funding
(Refer to Additional file 1).
Trials were considered as published in chiropractic
journals, if the journal was dedicated predominantly to
the advancement of chiropractic research, education and
health care (Refer to Additional file 1).
Statistical analysis description
This study used descriptive statistics to characterise the
overall quality of reporting of chiropractic RCTs, as well
as the key methodological items. The percentage of trials
that scored ‘yes’ to each CONSORT 2010 item were tab-
ulated and are presented in Table 2. The percentage of
trials that scored ‘yes’ to each item from the CONSORT
for Non-Pharmacological Treatments, are presented in
Table 3. The key methodological items are presented in
Table 4.
Two continuous variables were dichotomised. The
sample size variable was divided into a smaller group
with n = 1–100 and a larger group where n > 100. The
‘year of publication’ variable was also divided into two
time periods (2005–2007 and 2008–2014), which were
Table 1 Inclusion and exclusion criteria
Inclusion Criteria
RCTs with parallel or cross-over study design
Adult study populations with musculoskeletal and non-
musculoskeletal with conditions or no condition
Chiropractic high-velocity, low-amplitude (HVLA), musculoskeletal
manipulation
Treatment must include chiropractic manipulation, either spinal or
peripheral (or both) with/without adjunctive therapy (mobilization,
soft tissue therapy, massage, traction, electro-therapies, ultrasound, ex-
ercise advice, ergonomic advice, hot/cold therapy, back education)
Comparators: HVLA, placebo, sham treatment or conventional/
standard/usual care treatment, or no treatment
Exclusion Criteria
Reviews, systematic reviews and meta-analyses
Non-randomised trial designs (quasi-experimental, observational studies)
Pilot or feasibility studies
Studies with n-of-1
Studies evaluating diagnostic tests, prevention, prognosis, cost-
effectiveness, pathophysiological or mechanophysiological mechanisms,
validation of questionnaires
Trials not reported as full papers (abstracts), editorials, commentaries,
letters, case reports or series, audits, guidelines, historical articles
Methodological/Protocol, epidemiological and qualitative studies
Studies reporting updates of previously published RCTs
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used in an additional analysis. These time periods were
created to distinguish between chiropractic RCTs
published before and after the publication of the CON-
SORT Extension for Non-Pharmacological Treatments
statement.
All univariate regression analyses explored associations
between the outcome, i.e. the overall quality of reporting
score and the exploratory variables (i.e. industry funding,
positive findings, sample size group, year of publication
and journal type). To test these five exploratory vari-
ables, we constructed five univariate models, which in-
cluded each of the exploratory variables. The exploratory
variables that produced results that had a p ≤ 0.1, in the
univariate regression analysis, were included in the
Table 2 Frequencies of CONSORT 2010 items from customized overall quality of reporting checklist (N = 35)
Item Criterion CONSORT Description Total %
1a Title Identification as a randomised trial in the title 26 74
1b Abstract Structured summary of trial design, methods, results, and conclusions 35 100
2a Background Scientific background and explanation of rationale 35 100
2b Specific objectives or hypotheses 34 97
3a Trial Design Description of trial design (such as parallel, factorial) 18 51
4a Participants Eligibility criteria for participants 34 97
4b settings and locations where the data were collected 17 49
5 Interventions The interventions for each group with sufficient details to allow replication, including how
they were administered
32 91
6a Outcomes Completely defined pre-specified primary and secondary outcome measures 32 91
7a Sample size How sample size was determined 25 71
8a Sequence generation Method used to generate the random allocation sequence 29 83
9 Allocation concealment Mechanism used to implement the random allocation sequence (such as sequentially
numbered containers), describing any steps taken to conceal the sequence until
interventions were assigned
31 87
10 Implementation Was implementation discussed. Who generated the random allocation sequence,
who enrolled participants, and who assigned participants to interventions
26 74
11ai Blinding Whether or not participants, were blinded to group assignment 16 46
11aii Whether those assessing the outcomes were blinded to group assignment 25 71
12a Statistical methods Statistical methods used to compare groups for outcome(s) 35 100
13a Participant flow For each group, the numbers of participants who were randomly assigned, received
intended treatment, and were analysed for the primary outcome
29 83
13b For each group, losses and exclusions after randomization, together with reasons 20 57
14a Recruitment Dates defining the periods of recruitment and follow-up 23 66
15 Baseline data A table showing baseline demographic 32 91
16i Numbers Analysed Number of participants (denominator) in each group included in each analysis;
state the results in absolute numbers when feasible (e.g., 10/20, not 50 %)
16 46
16ii “Intention-to-treat” analysis 21 60
17ai Outcomes and estimation Primary outcome: a summary of results for each group and the estimated effect size
and its precision (e.g., 95 % confidence interval)
26 74
17aii Secondary outcome: a summary of results for each group and the estimated effect
size and its precision (e.g., 95 % confidence interval)
25 71
17b For binary outcomes, presentation of both absolute and relative effect sizes is
recommended
4 11
18 Ancillary Analyses Results of other analyses performed, including subgroup analyses and adjusted
analyses, distinguishing pre-specified
7 20
19 Adverse events All adverse events or side effects in each intervention group 22 63
20 Limitations Trial limitations 31 89
23 Registration Registration number 19 54
25 Funding Sources of funding and other support 32 91
Legend: Total: Total number of trials reporting item; %: Percentage of trials reporting item
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multivariate model [22, 39]. The intention for building
this multivariate regression model, was in order to ascer-
tain which of the exploratory variables were independ-
ently associated with higher overall quality of reporting
scores for the 35 RCTs included in this study. The
method used in the multivariate regression analysis was
stepwise approach. In the final multivariate regression
analysis, variables were considered statistically significant
if p < 0.05.
An additional ‘final’ multivariable model was cre-
ated. This model differed in that, the year of publica-
tion, which was originally used as a continuous
variable, was substituted for the dichotomous variable
(as described above). By dividing the year of publica-
tion variable into two time periods, pre and post
introduction of the CONSORT Extension for Non-
Pharmacological Treatments statement, we could
analyse the data to investigate whether this new
CONSORT statement, impacted the overall quality of
reporting.
Variation Inflation Factors (VIFs) were used to test
collinearity between exploratory variables. None of the
VIFS were >10, indicating that there was no collinearity
among the variables. All assumptions for normality and
linearity were checked using the Mahalanobis’ and
Cook’s Distance statistics. Statistical analyses were con-
ducted using SPSS © 22.0.0.0 (IBM Corporation 2013).
Results
Sources yielded a total of 21,331 trials. Of the 85 studies
that met the first round of inclusion criteria, only 35
(41 %) involving 4435 participants, were published as
full-text articles in English journals (Refer to Fig. 1 and
Additional file 1). These 35 articles, were assessed for
their overall quality of reporting. The RCTs involved
adult populations ranging between 17 and 78 years of
age. Twenty-five of the 35 (71 %) RCTs reported positive
findings in favour of the chiropractic intervention.
Seventeen of the 35 (49 %) RCTs were published in a
chiropractic journal. Only 43 % (15/35) of the RCTs
were industry funded. The sample sizes of the included
RCTs ranged between 20 and 444 participants with a
mean of 127 (SD ± 102).
Overall quality of reporting score
The overall quality of reporting score, ranged between
10 and 33 with median score of 26.0 (IQR = 8.00). Indi-
vidual scores are outlined in the Additional file 1. With
regard to reporting frequencies of individual CONSORT
items, refer to Tables 2 and 3.
Table 3 Frequencies of CONSORT for Non-Pharmacological Treatment statement items from customised overall quality of reporting
checklist (N = 35)
Item Criterion CONSORT Description Total %
1ext Abstract Does abstract include-description of the experimental treatment, comparator, care
providers, centers, and blinding status
11 31
3ext Methods When applicable, eligibility criteria for centers and those performing the
interventions (at least one)
13 37
4aext Interventions Description of the different components of the interventions and, when applicable,
descriptions of the procedure for tailoring the interventions to individual participants
29 83
4bext Details of how the interventions were standardised (if training was administered) 11 31
4cext Details of how adherence of care providers with the protocol was assessed or enhanced 1 3
8ext Randomization When applicable, how care providers were allocated to each trial group 11 31
13ext Flow Diagram The number of care providers or centers performing the intervention in each
group and the number of patients treated by each care provider or in each center
3 9
New Item Details of the experimental treatment and comparator as they were implemented 8 23
15ext Baseline data Description of care providers (case volume, qualification, expertise, etc.) and centers 8 23
Legend: Total: Total number of trials reporting item; %: Percentage of trials reporting item; ext: extension criteria from CONSORT for
Non-Pharmacological Treatments
Table 4 Frequencies of key methodological items from the customised CONSORT checklist (N = 35)
Item No. Criterion CONSORT Description Total %
9 Allocation concealment Mechanism used to implement the random allocation sequence (such as sequentially
numbered containers), describing any steps taken to conceal the sequence until
interventions were assigned
31 87
11ai Blinding Whether or not participants, were blinded to group assignment 16 46
11aii Blinding Whether those assessing the outcomes were blinded to group assignment 25 71
16ii Numbers Analysed “Intention-to-treat” analysis 21 60
Legend: Total: the total number of RCTs that reported this item; %: Percentage of trials reporting item
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Items that were most poorly reported from the CON-
SORT 2010 checklist were as follows: item 4b (settings
and locations where data were collected), with 17/35
(49 %) of trials reporting this; item 11(a)(i) (whether par-
ticipants were blinded) with 16/35 (46 %) of trials
reporting this; item 13b (the description of each groups
losses, exclusions and reasons within the flow diagram),
with 20/35 (57 %) reporting on this; item 16 (i) (num-
bers analysed….in absolute numbers e.g. 10/20, not
50 %) with 16/35 (46 %) of trials reporting this; item 19,
(the reporting of adverse events), with 22/35 (63 %) of
trials reporting this; and item 23, (the reporting of clin-
ical trial registration) with only 19/35 (54 %) of trials
reporting this (Refer to Table 2).
The items that were most underreported, were from
the CONSORT Extension for Non-Pharmacological
Treatments checklist, with only one of the nine items
achieving a high score. Item 4(a) extension requires the
reporting of the description of the different components
of the interventions and whether they were tailored to in-
dividuals, with 29/35 (83 %) of RCTs reporting this item.
All other items from the CONSORT for Non-
Pharmacological Treatments checklist were very poorly
reported with an overall quality of reporting score ranging
between 1/35 (3 %) for item 4c extension, (which details
how adherence of care providers with the protocol was
assessed or enhanced) through to 13/35 (37 %) for item 3
extension, (which describes the eligibility of centers or
care providers of the interventions) (Refer to Table 3).
The scoring of the key methodological items also revealed
some areas of weakness. Poor reporting of item 11(a)(i) (the
blinding of participants) which was reported in 16/35
(46 %) of RCTs, and item 16(ii) (the ITT analysis) which
was reported in 21/35 (60 %) of RCTs. The other two items
were reported more frequently (Refer to Table 4).
Results of statistical analyses
The univariate regression analysis revealed that year of
publication (t33 = 4.99, p = 0.000), journal type (t33 = 3.28,
p = 0.002), and sample size group (t33 = 2.75, p = 0.010),
were all individually and significantly associated with
overall quality of reporting (Refer to Table 5 and Figs. 2,
3, and 4 respectively).
The multivariate regression analysis subsequently re-
vealed that year of publication (t32 = 5.17, p = 0.000), and
sample size group (t32 = 3.01, p = 0.005), were the only
two factors associated with the overall quality of report-
ing. For each additional year between 2005 and 2014,
the overall quality of reporting score increased on aver-
age, by an estimated 1.26 points (95 % CI: 0.76,
1.76)(Refer to Table 5). Compared to the smaller sample
size group (n = 1–100), the larger sample size group (n >
100) scored on average 4.19 points higher (95 % CI:
1.36, 7.02) (Refer to Table 5).
The additional multivariate regression analysis con-
ducted with the two time periods for the year of publica-
tion, revealed that, compared to the period 2005–2007,
chiropractic RCTs published between 2008–2014, scored
on average 8.16 points higher (95 % CI: 4.64, 11.67)
(Refer to Table 5 and Fig. 5). The outcome was not af-
fected by this additional analysis, as the multivariate re-
gression analysis revealed that year of publication and
sample size were the only two factors associated with
the overall quality of reporting.
The final model in the multivariate regression ana-
lysis, revealed that 56 % of the variability in the
reporting quality of the included RCTs can be ex-
plained by later year of publication and larger sample
size (Adjusted R2 = 0.556).
Discussion
This appears to be the first study investigating the qual-
ity of reporting of chiropractic RCTs relative to the
CONSORT checklist. This study suggests, that there has
been a significant improvement in the reporting quality
of chiropractic RCTs between 2005 and 2014. This
may be explained by an increased uptake of the
CONSORT guidelines by journal editors and authors,
but also by an increasingly professional cadre of
chiropractic researchers. Furthermore, studies with
sample sizes with n > 100, also revealed this trend.
This is understandable, as studies with larger sample
sizes are associated with greater resources. Further-
more, studies with larger sample sizes are also more
likely to be adequately powered in order to find a
statistically significant result, if in fact one exists.
While recent publications were more likely to adhere
to the CONSORT 2010 criteria, the same cannot be said
Table 5 Univariate and multivariate regression analysis for





SE t p-value 95 % CI
Year of Publication 1.35 0.27 4.99 0.000 a 0.80, 1.90
Journal Type 5.81 1.77 3.28 0.002 a 2.21, 9.42
Sample Size Group 5.05 1.84 2.75 0.010 a 1.31, 8.80
Industry Funding 2.35 2.02 1.16 0.253 −1.76, 6.46
Positive Finding 3.30 2.18 1.51 0.140 −1.14, 7.74
Multivariate Regression Analysis
Year of Publication (1) 1.26 0.24 5.17 0.000 a 0.76, 1.76
Sample Size Group (1) 4.19 1.39 3.01 0.005 a 1.36, 7.02
Year of Publication Grp (2) 8.16 1.73 4.73 0.000 a 4.64, 11.67
Sample Size Group (2) 4.56 1.45 3.15 0.004 a 1.61, 7.51
Legend: a statistically significant result; SE Standard Error; t t-test statistic; CI
Confidence Interval; Grp Group; (1) Multivariate Analysis; (2) Additional analysis
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for the CONSORT Extension for Non-Pharmacological
Treatments criteria. Some specific areas, such as:
describing items related to care providers and centers,
details of adherence to protocols, and how interventions
were standardised and if training was administered as
prescribed, were very poorly reported. Perhaps this is
due to a lack of awareness within the chiropractic
research community of these extension criteria.
Under-reported items from the CONSORT 2010 state-
ment included: blinding; explanation of losses and
exclusions after randomization with reasons on the flow
chart; adverse event reporting; and analysis according to
ITT principles, despite the fact these criteria have been
established since the 2001 CONSORT statement [40].
Factors such as publishing in non-chiropractic journals
showed a trend towards improved quality of reporting
scores, although this was not statistically significant in
the multivariate regression analysis.
Industry funding was not associated with improved
quality of reporting of chiropractic RCTs. In contrast with
Fig. 2 Scatterplot of the correlation between the Overall Quality of Reporting Score and Year of Publication(N = 35)
Fig. 3 Boxplot of the distribution of Overall Quality of Reporting Scores for Chiropractic vs Non-Chiropractic Journals (N = 35)
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several medical studies [7, 16, 18, 24, 39, 43], and
some reviews [44, 45], which reported concerns that
industry funding may be associated with publication
bias [44–47].
We also found that a positive finding, was also not
associated with the overall quality of reporting within
the 35 chiropractic RCTs analysed. This was in con-
trast to several medical studies that reported that,
improved quality of reporting was associated with
positive findings [7, 39, 48]. One particular review
found that there was a positive association between
reporting of favorable outcomes among pharmaceu-
tical trials registered in ClinicalTrials.gov and indus-
try funding [48].
Transparency and accuracy of RCT reporting contrib-
utes to the evidence-based information for the profession
and will make assessing the validity of RCT results easier.
This in turn can lead to better decision-making, helping
chiropractic professionals improve their clinical decision
making and thus providing better outcomes for patients
Fig. 4 Boxplot of the distribution of Overall Quality of Reporting Scores for Sample Size 1–100 vs >100 (N = 35)
Fig. 5 Boxplot of the distribution of Overall Quality of Reporting Scores for Year of Publication by group, 2005–2007 vs 2008–2014 (N = 35)
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[49]. As the chiropractic profession is the largest non-
medical healthcare profession [50, 51], it is important to
continue developing the evidence base so as to inform
evidence-based practices. This in turn, will enable the
profession to maintain and broaden acceptance from
the public, mainstream healthcare and policy makers.
The insights gained from this study should be viewed
as an opportunity for improved reporting of RCTs and
increased awareness as to the importance of using the
CONSORT for Non-Pharmacologic Treatments state-
ment amongst chiropractic researchers. To enhance the
practice of evidence-based chiropractic care, researchers
are encouraged to implement the CONSORT guidelines
with greater rigor, especially in reporting of key methodo-
logical items, such as allocation concealment, blinding,
and the use of ITT analysis. As these key methodological
items can safeguard against bias in the execution and the
reporting of future RCTs.
It has been known for some time that the quality of
reporting has significantly improved in the medical lit-
erature with the adoption of the CONSORT guidelines
[10]. Similar outcomes have been reported in a physio-
therapy review [52], and a chiropractic review investigat-
ing low back and neck pain studies [53]. Our present
study suggests that the quality of reporting in chiroprac-
tic spinal and non-musculoskeletal studies has also
followed this trend.
Limitations
One limitation to this study was that it is possible that
our search strategy did not capture every available chiro-
practic RCT. We searched ten Clinical Trial registries
and two databases and only included published full-text
articles in the English language. Additionally, we could
not always verify the trial methodology from authors or
check their protocols.
Our assessment does not offer any insight into the ex-
ternal validity of the RCTs analysed, as it was too chal-
lenging to rate the reporting of such items [7], as there
have not yet been any scales developed that have been
validated to accomplish this task [39].
Although the CONSORT Extension for Non-
Pharmacological Treatments statement was published in
2008 [12], we decided to use time periods starting in
2005, because that was the year the International Com-
mittee of Medical Journal Editors published guidelines
that required trials to be registered prior to participant
enrolment as a precondition for publishing [54]. Further-
more, the original CONSORT was published in 1996 [6],
revised in 2001 [55], and again in 2010 [13], and the
original CONSORT items continue to exist in all the
versions of the CONSORT statements.
Another limitation to the study is that we cannot
generalize the results to all forms of chiropractic. We have
included studies, which used adjunctive techniques as
long as those RCTs also employed an HVLA procedure.
A potential weakness of this study is that, we created a
sum score for the overall quality of reporting and used it
for both descriptive purposes and as the dependent (out-
come) variable for the regression analysis. A problem
may be that the attributes we were adding are multi-
dimensional and it may not be appropriate to simply add
their scores together, as some items in the CONSORT
carry greater importance than others. Furthermore, two
RCTs may receive the same score but differ in the areas
considered deficient with respect to reporting. This can
make the overall quality of reporting score somewhat
difficult to interpret between studies.
Conclusion
Reporting quality of RCTs varies widely in chiropractic
research. While steady improvement has been observed
over the last decade, the chronological improvement ob-
served in this study appears to reflect a more thorough
and stringent adoption of the CONSORT criteria. This
study suggests that quality reporting was influenced by
year of publication and sample size and may also have
been be influenced by factors such as journal choice, but
not funding source or outcome positivity. This should
be regarded as a reassuring finding for the profession
and scientific community.
Recommendations
In light of these findings, we have made some simple
recommendations for the improvement of reporting of
future chiropractic RCTs.
1: Researchers are encouraged to design and fully
report studies to meet the requirements of
CONSORT 2010 statement, with extra emphasis on
key methodological items:- allocation concealment,
blinding of participants and assessors and the use of
ITT analysis.
2: Researchers are encouraged to incorporate items from
the CONSORT Extension for Non-Pharmacological
Treatments statement.
3: Researchers must register their clinical trials, which
is in alignment with the standards established by the
International Committee of Medical Journal Editors
in 2005.
4: Chiropractic journals could exhort researchers to
publish the protocols for RCTs in their respective
journals for assessment of the study and statistical
review, with the understanding that their results are
more likely to be published if the protocol meets the
CONSORT criteria. (The Lancet is just one of
several medical journals that encourages this
practice)
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